Cell DeathAntineoplastic Combined Chemotherapy ProtocolsCause of DeathChemotherapy, AdjuvantApoptosisDeathAntineoplastic AgentsCisplatinCombined Modality TherapyTreatment OutcomeDoxorubicinCaspasesCyclophosphamideCell SurvivalSurvival AnalysisDeath, Sudden, CardiacEtoposideBreast NeoplasmsPrognosisTime FactorsSurvival RateNeoadjuvant TherapyCell Line, TumorNecrosisCaspase 3Brain DeathProto-Oncogene Proteins c-bcl-2Disease-Free SurvivalLung NeoplasmsNeoplasmsNeoplasm StagingDrug Administration ScheduleDNA FragmentationFetal DeathSignal TransductionPaclitaxelFollow-Up StudiesMitochondriaDrug Resistance, NeoplasmMethotrexateAutophagyCarboplatinIn Situ Nick-End LabelingAttitude to DeathVinblastinebcl-2-Associated X ProteinDose-Response Relationship, DrugCaspase InhibitorsNeoplasm Recurrence, LocalInduction ChemotherapyTaxoidsCells, CulturedAntigens, CD95Reactive Oxygen SpeciesAntineoplastic Agents, PhytogenicProspective StudiesAntimetabolites, AntineoplasticIfosfamideBleomycinDeoxycytidineOrganoplatinum CompoundsAntineoplastic Agents, AlkylatingRisk FactorsTumor Cells, CulturedCell LineEnzyme ActivationAnthracyclinesKaplan-Meier EstimateOvarian NeoplasmsCytarabineCarcinoma, Non-Small-Cell LungTumor Suppressor Protein p53Caspase 8AdenocarcinomaReceptors, Death DomainNeuronsAmino Acid Chloromethyl KetonesNeoplasm MetastasisPoly(ADP-ribose) PolymerasesCaspase 9Salvage TherapyChemotherapy, Cancer, Regional PerfusionCytochromes cFas Ligand ProteinImmunohistochemistryBlotting, WesternCysteine Proteinase InhibitorsColorectal Neoplasmsbcl-X ProteinAntibiotics, AntineoplasticCell ProliferationMutationTesticular NeoplasmsLymphoma, Non-HodgkinNeutropeniaTransplantation, AutologousApoptosis Regulatory ProteinsBrain NeoplasmsVomitingCamptothecin